PCR published a 100-page research report with a buy recommendation and arranged analyst briefings and regular monthly and quarterly publications that garnered interests from foreign investment banks and stockbroking houses. Subsequently, several large foreign and domestic stockbrokers agreed to publish "buy" research reports on BB and took them to global roadshows. BB succeeded in raising a US$200 million rights issue, the largest in the JSX history then, and was rated "buy" by nearly all leading stockbrokers. Since then, it has received numerous privileged invitations to join global investor forums and roadshows sponsored by global and regional stockbrokers. In 2006, BB was named the best investor relations company in Indonesia by the prestigious Asia Money magazine.

PCR helped BB to unlock shareholder value by (i) raising its market value (capitalisation) more than 4 times in 3.5 years from US$170 million to nearly US$1 billion, (ii) placing it in the coverage list of many global stockbrokers, and (iii) bolstering its investor-relation reputation to be voted the best by the Asia Money.

PCR published a 60-page buy research report when stock price was Rp375. Subsequently, it attracted 2 international stockbrokers to publish buy reports and arranged a domestic and global road show. In 6- month time, BFI's stock price soared more than 3 times to Rp1,600 and it became one of the most frequently traded stocks in JSX. BFI garnered shareholders' supports throughout its 4 years of trial that culminated in its winning the litigation case in the Supreme Court and Court of Appeal. During the difficult period of litigation, PCR managed to raise bank loans for BFI.

PCR helped BFI to boost its market capitalisation by 3 times in 4 years from US$26 million to US$110 million.

PCR published a buy research report on the company, convinced leading foreign stockbrokers to write buy reports, and arranged global roadshows. Through regular monthly and quarterly publications and analyst briefings, BSP won the trust of many global investors. It received many invitations for global roadshows and investor forums, and its share price nearly tripled in just a year. In 2006, BSP was nominated as one of the best companies in corporate governance. Armed with a great corporate image, BSP successfully issued US$160 million bonds in 2006-2007 and raised a US$250 million strategic partnership fund plus US$174 million rights issue in late 2007.

In 3 years, PCR assisted BSP to boost its market capitalisation by 9 times from less than US$100 million to US$1billion.